Adenocarcinoma of the Esophagogastric Junction
📧 Sign up to get email alerts when something new happens for Adenocarcinoma of the Esophagogastric Junction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction [Phase 2]
A Phase 2 clinical trial update evaluating serplulimab in combination with chemotherapy as neoadjuvant therapy for locally advanced gastric …
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Adenocarcinoma of Gastric/Esophagogastric Junction [Phase 1]
A Phase 1 study of IM96 CAR-T Cell Therapy for advanced gastric adenocarcinoma and esophagogastric junction adenocarcinoma. The trial status…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: Intraoperative Margin Techniques for Esophagogastric Junction Adenocarcinoma: A Controlled Study [NA]
This entry describes a controlled clinical trial investigating intraoperative margin techniques for esophagogastric junction adenocarcinoma,…
-
CLINICAL_TRIALS research · 2024-11-08Clinical Trial Update: Comparison of Different Operations for Siewert Type II Adenocarcinoma of Esophagogastric Junction [NA]
A recruiting clinical trial at Xijing Hospital is comparing different surgical operations for Siewert Type II adenocarcinoma of the esophago…
-
CLINICAL_TRIALS research · 2024-11-08Clinical Trial Update: A Multi-center, Two-arm, Phase 2 Clinical Study on the Perioperative Treatment of HER2-positive Resectable Esophagogastric Junctional Adenocarcinoma With Nabulimab Combined With FLOT and Trastuzumab VS FLOT Combined With Trastuzumab [Phase 2]
Multicenter, two-arm Phase 2 trial evaluating perioperative therapy for HER2-positive resectable esophagogastric junctional adenocarcinoma, …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-07-08Clinical Trial Update: TQB2450 Plus Anlotinib Combined With Chemotherapy in the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma [NA]
Clinical trial update on a combination of TQB2450, Anlotinib, and chemotherapy for gastric cancer and esophagogastric junction adenocarcinom…
-
CLINICAL_TRIALS research · 2024-07-01Clinical Trial Update: Neoadjuvant Immunochemotherapy for Adenocarcinoma of the Esophagogastric Junction [Phase 2]
Phase 2 clinical trial evaluating neoadjuvant immunochemotherapy for adenocarcinoma at the esophagogastric junction; the study is currently …
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Perioperative Chemotherapy Compared To Neoadjuvant Chemoradiation in Patients With Adenocarcinoma of the Esophagus [Phase 3]
This clinical trial update describes a Phase 3 study comparing perioperative chemotherapy to neoadjuvant chemoradiation for esophageal adeno…
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: The Efficacy and Safety of Tislelizumab Combined With Anlotinib and S1 Plus Oxaliplatin as Neoadjuvant Therapy for the Locally Advanced Adenocarcinoma of Esophagogastric Junction [Phase 2]
A Phase 2 neoadjuvant trial evaluating a combination of tislelizumab, anlotinib, S-1, and oxaliplatin for locally advanced adenocarcinoma of…
-
CLINICAL_TRIALS research · 2017-12-11Clinical Trial Update: Length of the Proximal Resection Margin for Siewert-II/Siewert-III Tumors [NA]
A clinical trial update concerning the proximal resection margin length for Siewert II/III esophagogastric junction tumors; the current stat…
-
CLINICAL_TRIALS research · 2017-02-07Clinical Trial Update: mFOLFOX Versus mFOLFIRI Versus FOLFPTX as First-line Treatment in AGC or EGJA [NA]
A clinical trial compares three first-line regimens—mFOLFOX, mFOLFIRI, and FOLFPTX—for advanced gastric cancer and esophagogastric junction …
-
CLINICAL_TRIALS research · 2016-04-18Clinical Trial Update: Minimally Invasive Sweet Esophagectomy for Patients With Siewert Type II Adenocarcinoma of the Esophagogastric Junction [NA]
This entry reports a clinical trial update for a minimally invasive esophagectomy approach in patients with Siewert Type II adenocarcinoma o…